Name,Types of treatment ,Sex,Reccurence,Menopausal status,Tissue status,Stage,Inflammatory status,Mestastatic status,ER,HER2,NEU2,Tumor size,Mamaprint score,Oncotype DX scoreTAK-700,Hormone therapy,Female,N/A,Postmenopausal,Not determine,Stage III,Yes ,Yes,Positive,Positive,Negative,2.1cm-5.0cm,Not tested,Not testedFemara,Hormone therapy,Female,N/A,Postmenopausal,Ductal Carcinoma In Situ,In Situ,No,No,Negative,Positive,Negative,Less than 2.0cm,Low,LowEstradiol ,Hormone therapy,Female,N/A,Postmenopausal,Not determined,Not determined,Yes ,Yes,Positive,Positive,Not tested,2.1cm-5.0cm,Low,LowAromasin,Hormone therapy,Female,N/A,Postmenopausal,Not determined,Not determined,Yes ,Yes,Positive,Positive,Not tested,2.1cm-5.0cm,Low,LowEndoxifen,Hormone therapy,Female,Yes ,N/A,Not determined,Not determined,Yes ,Yes,Positive,Positive,Not tested,Not sure,High ,High Letrozole,Hormone therapy,Female,N/A,Postmenopausal,Lobular Carcinoma,Stage III,Yes ,Yes,Positive,Positive,Positive,Not sure,High ,Not testedLepatinib,Hormone therapy,Female,N/A,Postmenopausal,Lobular Carcinoma,Stage III,Yes ,Yes,Positive,Positive,Positive,Not sure,Not tested,LowHerceptin,Targeted therapy,Female,N/A,Premenopausal,Not determined,Stage III,Yes ,Yes,Negative,Positive,Negative,Not sure,Not tested,LowEroltinib,Targeted therapy,Female,N/A,Premenopausal,Lobular Carcinoma,Stage II,No,No,Negative,Negative,Negative,Not sure,Not tested,LowTykerb,Targeted therapy,Female,N/A,Premenopausal,Not determined,Stage III,Yes ,Yes,Positive,Positive,Negative,2.1cm-5.0cm,High ,High Ixabepilone,Targeted therapy,Female,N/A,Postmenopausal,Lobular Carcinoma,Stage IV,No,Yes,Positive,Positive,Negative,Less than 2.0cm,High ,High 